Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

Dr. Sudhir Chandra Sarangi

 

 

Name: Dr. Sudhir Chandra Sarangi, MBBS, MD, DM, MAMS

Designation: Assistant Professor

Affiliation: Department of Pharmacology, AIIMS, New Delhi

Address: Room No-5009, 5th Floor,

                 Department of Pharmacology,

                 Convergence Block,

                 All India Institute of Medical Sciences,

                 New Delhi-110029

Phone: 011-26549259

Email Id यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

Academic Details:

  • D.M. (Clinical Pharmacology) in the year 2013, All India Institute of Medical Sciences, New Delhi.

  • M.D. (Pharmacology)  in the year 2009, All India Institute of Medical Sciences, New Delhi

  • M.B.B.S (Hons)  in the year 2005, MKCG Medical College, Berhampur

Research Interest/Areas: Clinical Pharmacology, Neuropharmacology, Pharmacovigilance, Drug Safety, Pharmacoeconomics, Computational Pharmacology

Fellowships/ Memberships/ Awards:

  • Awarded membership by National Academy of Medical Sciences

  • Obtained Certificate of Achievement for poster presentation at 32nd International Epilepsy Congress, 2017.

Life Membership of societies:

  • Indian Pharmacology society

  • Indian Society of Rational Pharmacotherapeutics

  • The Association of Physiologists & Pharmacologist of India

  • Society of  Toxicology, India

  • Indian Epilepsy Society

  • Indian Society of Nanomedicine

Key publications:

  1. Sarangi SC, Kaur N, Tripathi M, Gupta YK. Cost analysis study of neurological drugs: Role of National List of Essential Medicines, India. Neurology India. Accepted.

  2. Kakkar AK, Gulati S, Sarangi SC, Gupta YK. Effects of long term antiepileptic therapy on serum trace element levels in epileptic children. Interdisciplinary Toxicology. Accepted.

  3. Singh H, Sarangi SC, Gupta YK. French Phase I clinical trial disaster: Issues, learning points, and potential safety measures. J Nat ScBiol Med 2018;9:106-10.

  4. Goyal A, Singh H, Sehgal VK, ..., Sarangi SC, Gupta YK. Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study. Indian J Med Res. 2017 Oct;146(4):468-475.

  5. Sarangi SC, Joshi D, Kumar R, Kaleekal T, Gupta YK. Pharmacokinetic and pharmacodynamic interaction of hydroalcoholic extract of Ocimum sanctum with valproate. Epilepsy Behav. 2017 Oct;75:203-209.

  6. Sarangi SC, Tripathi M, Kakkar AK, Gupta YK. Body composition comparison in persons with epilepsy on conventional and new antiepileptic drugs. Indian J Med Res. 2016 Mar;143(3):323-30.

  7. Sarangi SC, Kakkar AK, Kumar R, Gupta YK. Effect of lamotrigine, levetiracetam and topiramate on neurobehavioral parameters and oxidative stress in comparison with valproate in rats. Indian J Med Res. 2016 Jul;144(1):104-111.

  8. Sarangi SC, Tripathi M, Kakkar AK, Gupta YK. Effect of antiepileptic therapy on trace elements status in Indian population in a tertiary care hospital from northern India: A cross sectional study. Epilepsy Res. 2014;108(5):917-27.

  9. Medhi B, Mittal N, Bansal D, Prakash A, Sarangi SC, Nirthi B. Comparison of tolterodine with standard treatment in pediatric patients with non-neurogenic dysfunctional voiding/over active bladder: A systematic review. Indian J PhysiolPharmacol. 2013 Oct-Dec;57(4):343-53.

  10. Sarangi SC, Reeta KH, Agarwal SK, Kaleekal T, Guleria S, Gupta YK. A pilot study on area under curve of mycophenolic acid as a guide for its optimal use in renal transplant recipients. Indian J Med Res. 2012;135:84-91.

             

Dr Jagriti Bhatia

 

Designation:                           Professor

Office Address:                     Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi  110 029 

Office Tel:                              011-2654 6476;  26593282

E-mail:                                    यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

Education:                             MBBS (Lady Hardinge Medical College, New Delhi, 1995) 

                                                MD Pharmacology (UCMS-GTB Hospital, Delhi, 1999)

Departmental duties:            Engaged in teaching of  MBBS (3rd, 4th and 5th Semester), BSc Nursing (Hons), MSc, MD and PhD students

Field of Research:                 Herbal (Indigenous) Pharmacology

                                                Cardiovascular Pharmacology

                                                Nephrotoxicity

                                                Pulmonary fibrosis

 

Awards

 

  1. AIIMS Excellence Research Award 2015 Commendation Certificate for the year 2014-2015.
  2. ISH 2014 International Forum Poster Prize for the Asia and Australasia Region at Athens, Greece, 2014.

Research Publications

  1. Gamad N,  Malik S, Suchal K, Vasisht S, Tomar A, Arava S, Arya DS, Bhatia J. Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms. Biomed Pharmacother  2018; 97: 1544–1553.
  2. Khan SI, Malhotra RK, Rani N, Sahu AK, Tomar A, Garg S, Nag TC, Ray R, Ojha S, Arya DS, Bhatia J. Febuxostat Modulates MAPK/NF-κBp65/TNF-α Signaling in Cardiac Ischemia-Reperfusion Injury.Oxid Med Cell Longev. 2017;2017:8095825. 
  3. Tomar A, Vasisth S, Khan SI, Malik S, Nag TC, Arya DS, Bhatia J. Galangin ameliorates cisplatin induced nephrotoxicity in vivo by modulation of oxidative stress, apoptosis and inflammation through interplay of MAPK signaling cascade. Phytomedicine.2017;34:154-161.
  4. Malik S, Suchal K, Khan SI, Bhatia J, Kishore K, Dinda AK, Arya DS. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK/NF-κB/TNFα and TGF-β1/MAPK/Fibronectin pathways.Am J Physiol Renal Physiol.2017;313(2):F414-F422.
  5. Suchal K, Malik S, Gamad N, Malhotra RK, Goyal SN, Bhatia J, Arya DS. Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats.Phytomedicine. 2016;23(12):1401-1408.
  6. Malik S, Suchal K, Bhatia J, Khan SI, Vasisth S, Tomar A, Goyal S, Kumar R, Arya DS, OjhaSK.Therapeutic Potential and Molecular Mechanisms of Emblica officinalisGaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin. Front Pharmacol 2016;7:350. eCollection 2016.
  7. Rani N, Bharti S, Tomar A, Dinda AK, Arya DS, Bhatia J. Inhibition of PARP activation by enalapril is crucial for its renoprotective effect in cisplatin-induced nephrotoxicity in rats.Free Radic Res 2016;50(11):1226-1236.    
  8. Malik S, Suchal K, Bhatia J, Gamad N, Dinda AK, Gupta YK, Arya DS. Molecular mechanisms underlying attenuation of cisplatin-induced acute kidney injury by epicatechingallate. Lab Invest.2016; 96(8):853-61.
    1. Malik S, Suchal K, Gamad N, Dinda AK, Arya DS, Bhatia J .Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis.Eur J Pharmacol. 2015; 748:54-60.  
  1. Malik S, Bhatia J, Suchal K, Gamad N, Dinda AK, Gupta YK, Arya DS. Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects.ExpToxicolPathol. 2015;67(7-8):427-33. 

 

Dr. Harlokesh Narayan Yadav

 

Name : DR. Harlokesh Narayan Yadav      

Present Status  : Assistant Professor

Educational Qualifications:

 M.Pharm. (Pharmacology), Ph.D 

 

Email: यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

Ph. No: 011-26549265

 

Research Interests/ Active Research Areas:

  • Cardiovascular Pharmacology
  • Molecular Pharmacology
  • Nanomedicine

Awards:

  • Dr. Manjeet Singh Award (2010) by Indian Pharmacological society.
  • NN Datta Prize (2010) by Indian Pharmacological society.

 

Guided: 41 PG Students 

 

Selected Research Publications:

  1. Vishwakarma V, Goyal A, Gupta JK, Upadhyay PK, Yadav HN (2017), Involvement of atrial natriuretic peptide in abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart, Human and Experimental Toxicology, Vol. 37(7) 704–713
  2. Gupta I, Goyal A, Singh NK, Yadav HN, Sharma PL (2017), Hemin, a heme oxygenase-1 inducer, restores the attenuated cardioprotective effect of ischemic preconditioning in isolated diabetic rat heart, Hum Exp Toxicol, 36: 867-875.
  3. Charan K, Goyal A, Gupta GK, Yadav HN (2016), Role of atrial natriuretic peptide in  ischemic preconditioning–induced cardioprotection in the diabetic rat heart, Journal of Surgical Research, 201:272-8 
  4. Goyal A, Semwal BC, and Yadav HN (2015), Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart. Human and Experimental Toxicology, 35; 644-53.
  5. Ajmani P, Yadav HN, Singh M and Sharma PL (2011), Involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. BMC Cardiovascular Disorders, 11, 43.
  6. Arya A, Yadav HN, and Sharma PL (2011), Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats. Journal of Molecular and Cellular Biochemistry, 354; 57-66.
  7. Yadav HN, Singh M, and Sharma PL (2010), Modulation of cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart. European journal of pharmacology, 643; 78-83.
  8. Yadav HN, Singh M, and Sharma PL (2010), Involvement of GSK-3β in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. Journal of Molecular and Cellular Biochemistry. 343; 75-81.
  9. Taliyan R, Singh M, Sharma PL, Yadav HN and Sidhu KS (2010), Possible involvement of alpha-1 adrenergic receptor and KATP channels in cardioprotective effect of remote aortic preconditioning in isolated rat heart. Journal of Cardiovascular Disease Research, 1; 145-152.

Garg K, Yadav HN, Singh M and Sharma PL (2010), Mechanism

                                                                      

DR. SURENDER SINGH

 

DR. SURENDER SINGH

 

DOB: 27th May1963

PROFESSOR

Department of Pharmacology,

All India Institute of Medical Sciences,

Ansari Nagar New Delhi - 110 029, INDIA

Tel: +91-11-2654-6460,  09810882350

E-mail:  यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

 

RESEARCH AND PUBLICATIONS

ACADEMIC ACHIEVEMENTS

1. Published >100 Research Papers (Total Impact Factor 125.02, Citation-3200, h-Index- 29)

2. Authored 06 Books/Scientific Series & chapters in book.

3. Guided 48 Theses (PhD-18, MD/MDS -19, M.Pharm / MSc-08).

4. Completed 20 Research projects funded by ICMR, DBT, AIIMS, AYUSH, Govt. of India.

Awards:

1.Gold Medal, M.Pharm. (Pharmacology) DIPSAR (University of Delhi), 1989.

2.JSPS-Asia Africa Science Platform Programme, Japan Best Paper Award, 2011.

3. Indian Council of Medical Research (ICMR) Award for Biomedical Research, 2013.

4. All India Institute of Medical Sciences (AIIMS) Excellence Research Award, 2016.

5. Dr. B. Mukherjee Prize for Best paper in Indian Journal of Pharmacology, 2016.

6. Dr. D.N. Prasad Memorial Oration Award, ICMR for Biomedical Research, 2017.

 

Fellowships/ Honours:

1. Fellow of National Academy of Medical Sciences (FAMS), India.     

2. Fellow of Royal Society of Chemistry (FRSC), United Kingdom.

3. Fellow of International Medical Science Academy (FIMSA), India.

4. Fellow of Institution of Chemists (FIC), India.

5. D.Sc. (Honoris Causa), Colombo, Sri Lanka.

6. Fellow of International Council of Ayurveda (FICA), India.

 

RESEARCH AREA

Inflammation, Rheumatoid Arthritis, Indigenous drugs, Medicinal Plant Research

RESEARCH PAPERS

1.   Surender Singh and DK Majumdar (1999).

      Evaluation of gastric antiulcer activity of fixed oil of Ocimum sanctum (Holy Basil)

      Journal of Ethnopharmacology, 65:13-19. (IF:3.055)             

2.   MA Jafri, M Jalis Subhani, Kalim Javed and Surender Singh (2000)

      Hepatoprotective activity of leaves of Cassia Occidentalis against paracetamol and ethyl alcohol intoxication in rats.

      Journal of Ethnopharmocology - 66:355-361. (IF:3.055)             

3.   MA Jafri, M Aslam, Kalim Javed and Surender Singh (2000)

      Effect of Punica granatum Linn (flowers) on blood glucose levels in normal and alloxan induced diabetic rats.

      Journal of Ethnopharmacology - 70:309-314. (IF:3.055)               

4.   MA jafri, Farah, Kalim Javed K and Surender Singh (2001)

      Evaluation of the gastric antiulcerogenic effect of large cardamom (fruits of Ammomum subulatum Roxb.)

      Journal of Ethnopharmacology 75:89-94. (IF:3.055)  

          

5.   Surender Singh, HMS Rehan and DK Majumdar (2001)

      Effect of Ocimum sanctum fixed oil on blood pressure, blood clotting time and pentobarbitone - induced sleeping time.

      Journal of Ethnopharmacology ,78:139-143. (IF:3.055)             

6.   PK Mediratta, KK Sharma and Surender Singh (2002)

      Evaluation of Immunomodulatory potential of Ocimum sanctum seed oil and its possible mechanism of action.

      Journal of Ethnopharmacology, 80:15-20. (IF:3.055)             

          

7. Vinod Nair , Surender Singh and YK Gupta (2011).

Evaluation of the disease modifying activity of Colchicum luteum Baker in. experimental arthritis.

      Journal of Ethnopharmacology, 133: 303-307. (IF:3.055)             

 

8.Surender  Singh, Vinod Nairand Yogendra K Gupta (2012).

     Evaluation of the aphrodisiac activity of Tribulus terrestris Linn. in sexually sluggish male albino rats.

      Journal of Pharmacology & Phamacotherapeutics , 3(1): 43-47.

 

9. Ritu Karwasra, Prerna Kalra, YK Gupta, Deepika Saini, Ajay Kumar and Surender        Singh (2016).

Pomegranate antioxidant and anti-inflammatory potential ameliorates renoprotection  in cisplatin-induced acute kidney injury.

Food and Function, 7: 3091-3101 (IF: 2.791).

10. Rohit Kumar, Vinod Nair, YK Gupta, Surender Singh and S.Arunraja (2016).

Berberis aristata ameliorates adjuvant-induced arthritis by inhibition of NF-κB and       activating nuclear factor-E2-related factor 2/hem oxygenase (HO)-1 signaling pathway.

Immunological investigations, 45(6): 473-489. (IF: 1.780).

 

Top of Page